Lymphocyte predominant Hodgkin Disease: Clinico-pathologic features and results of treatment—The pediatric oncology group experience-Reference-Cited by-同舟云学术

Lymphocyte predominant Hodgkin Disease: Clinico-pathologic features and results of treatment—The pediatric oncology group experience

Published:1997-12 Issue:6 Volume:29 Page:519-525
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Karayalcin Gungor,Behm Fred G.,Gieser Peter W.,Kung Faith,Weiner Michael,Tebbi Cameron K.,Ferree Carolyn,Marcus Robert,Constine Louis,Mendenhall Nancy P.,Chauvenet Allen,Murphy Sharon B.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Reference39 articles.

1. Correlation of histopathology with other prognostic indicators in Hodgkin's disease

2. Hodgkin's Disease: Retrospective clinico-pathologic study in 149 patients

3. Epidemiology of nodular paragranuloma (Hodgkin's disease with lymphocytic predominance, nodular)

4. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular)

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presentation of B-cell lymphoma in childhood and adolescence: a systematic review and meta-analysis;BMC Cancer;2024-06-11

2. The impact of immunoarchitectural patterns on clinical presentation and response to therapy in children with nodular lymphocyte predominant Hodgkin lymphoma;Pediatric Hematology/Oncology and Immunopathology;2024-04-15

3. Recommandations de la SFCE pour la prise en charge du lymphome de Hodgkin nodulaire à prédominance lymphocytaire de l’enfant et de l’adolescent;Bulletin du Cancer;2023-09

4. Nodular lymphocyte-predominant Hodgkin Lymphoma in children. Retrospective clinical and morphological analysis of the patients. One Center experience;Pediatric Hematology/Oncology and Immunopathology;2021-05-22

5. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children's Oncology Group;Pediatric Blood & Cancer;2018-09-14